- Home
- NXC vs PMVP Comparison
NXC vs PMVP Comparison
Compare NXC & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$1.24
Company Overview
Basic Information| Metric | NXC | PMVP |
|---|---|---|
| Founded | 1992 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.2M | 66.0M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | NXC | PMVP |
|---|---|---|
| Price | $13.22 | $1.24 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | 17.5K | ★ 269.9K |
| Earning Date | 01-01-0001 | 11-12-2025 |
| Dividend Yield | ★ 3.97% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.19 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $70.47 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.86 | $0.81 |
| 52 Week High | $13.70 | $1.84 |
Technical Indicators
Market Signals| Indicator | NXC | PMVP |
|---|---|---|
| Relative Strength Index (RSI) | 55.11 | 47.47 |
| Support Level | $13.10 | $1.20 |
| Resistance Level | $13.27 | $1.25 |
| Average True Range (ATR) | 0.12 | 0.07 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 88.12 | 70.27 |
Price Performance
Historical Comparison NXC
PMVP
About NXC Nuveen California Select Tax-Free Income Portfolio
Nuveen CA Select Tax Free Income Port is a diversified closed-end management investment company. Its objective is to provide stable dividends exempt from both regular federal and California income taxes, consistent with the preservation of capital by investing in municipal obligations.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.